Roger Godsiff – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Roger Godsiff on 2016-03-24.

To ask the Secretary of State for Health, for what reason NHS England decided not to proceed with the Truvada commissioning process; and what plans the Government has to make that drug available on the NHS.

Jane Ellison

NHS England does not now consider pre-exposure prophylaxis (PrEP) for HIV is suitable for prioritisation of specialised commissioning spend as it is a preventative measure. However given the potential benefits in this area, NHS England is keen to build on the work to date and will be making available up to £2 million over the next two years to run a number of early implementer test sites. These will be undertaken in conjunction with Public Health England and will seek to answer the remaining questions around how PrEP could be commissioned in the most cost effective and integrated way to reduce HIV and sexually transmitted infections in those at highest risk.